Exclusive

Publication

Byline

Generative AI for Startups in 2026: How Startups Are Really Using It

New Delhi, April 3 -- Startups do not have a problem with awareness when it comes to artificial intelligence. They have a problem with clarity. By 2026, every founder knows that AI can accelerate wor... Read More


Canadian national arrested at BIA with over 21kg of Kush cannabis

Sri Lanka, April 3 -- A foreign passenger attempting to smuggle a consignment of 'Kush' cannabis, estimated to be valued at Rs. 217.79 million, into Sri Lanka was arrested by officers of the Police Na... Read More


Iran Plans Strait of Hormuz 'Monitoring' Proposal with Oman Amid Rising Tensions

India, April 3 -- Iran on Thursday said it is drafting a proposal with Oman to "monitor" the Strait of Hormuz, a critical global shipping route, amid ongoing regional tensions. The announcement was m... Read More


Telangana drug party busted: EAGLE force raids Hyderabad pub, 7 detained for consuming narcotic drugs

New Delhi, April 3 -- The EAGLE (Elite Action Group for Drug Law Enforcement) force in Telangana capital Hyderabad said on Friday that it conducted a raid on a local pub, apprehending seven people for... Read More


"Will probe alleged ties between CM Sarma and Shyam Kanu Mahanta": APCC President Gogoi

Guwahati, April 3 -- Assam Pradesh Congress Committee (APCC) President Gaurav Gogoi and Assam Jatiya Parishad (AJP) President Lurinjyoti Gogoi visited Sarupathar on Friday to campaign for opposition a... Read More


What's wrong with Tiger Woods? 'Heartbreaking' video after DUI arrest leaves fans worried, 'Mental health is real'

New Delhi, April 3 -- Just after crashing his SUV in Florida on March 27, Tiger Woods told authorities he had been speaking to "the president". Newly released bodycam footage shows deputies approachin... Read More


Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, April 3 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the po... Read More


Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, April 3 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507... Read More


Singapore Clinical Trial: A Phase 1, Open-Label, Single Dose Study to Investigate the Relative Bioavailability, Safety, and Tolerability of Two Formulations of Eltrekibart in Healthy Participants

Singapore, April 3 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Open-Label, Single Dose Study to Investigate the Relative Bioavailability, Safety, and ... Read More


Singapore Clinical Trial: ROSETTA HCC-206: An Open-Label, Multi-Center, Randomized Phase 1/2 Study of Pumitamig Alone or In Combination with Ipilimumab in Participants with First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC)

Singapore, April 3 -- The Health Sciences Authority received information related to the study titled 'ROSETTA HCC-206: An Open-Label, Multi-Center, Randomized Phase 1/2 Study of Pumitamig Alone or In ... Read More